3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
Gastrointestinal
1
Conditions
Gliosarcoma
87
Glioblastoma
85
Sarcoma
82
Central Nervous System Neoplasms
50
Dendritic Cell Sarcoma, Interdigitating
33
Lymphoma
31
Burkitt Lymphoma
30
Precursor Cell Lymphoblastic Leukemia-Lymphoma
27
Lymphoma, Non-Hodgkin
26
Lymphoma, Large-Cell, Immunoblastic
26
Lymphoma, Large B-Cell, Diffuse
26
Leukemia
26
Lymphoma, Follicular
24
Lymphoma, Mantle-Cell
23
Myelodysplastic Syndromes
22
Leukemia, Lymphocytic, Chronic, B-Cell
22
Lymphoma, B-Cell, Marginal Zone
21
Leukemia, Myeloid, Chronic-Phase
21
Recurrence
20
Astrocytoma
20
Leukemia, Myeloid, Accelerated Phase
19
Hodgkin Disease
19
Blast Crisis
18
Multiple Myeloma
17
Leukemia, Myeloid, Acute
17
Liposarcoma
16
Glioma
16
Rhabdomyosarcoma
15
Neoplasms, Plasma Cell
15
Brain Neoplasms
14
Interventions
Imatinib Mesylate
71
Sunitinib
31
regorafenib
17
nilotinib
15
ripretinib
13
avapritinib
7
Laparoscopy
5
Ipilimumab
5
Dasatinib
5
spartalizumab
4
CTLA-4 Antigen
4
Blood Specimen Collection
4
4-amino-5-fluoro-3-(5-(4-methylpiperazin-1-yl)-1H-benzimidazol-2-yl)quinolin-2(1H)-one
4
pexidartinib
3
pazopanib
3
binimetinib
3
Temozolomide
3
Surveys and Questionnaires
3
Surgical Procedures, Operative
3
Paclitaxel
3
Oxaliplatin
3
Observation
3
Nivolumab
3
Midazolam
3
Leucovorin
3
Gemcitabine
3
Biopsy
3
Bevacizumab
3
trametinib
2
tanespimycin
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Gastrointestinal Stromal Tumors
×
Radiotherapy
×
Sarcoma
×
Clear all
NCT00515931
2014-10-07
GIST-RT
University of Helsinki
Phase 1/2
Completed
25 enrolled